Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 6/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 6/20 | 0.50 |
| ▸ | MAPT | P10636 | 6/20 | 0.50 |
| ▸ | HTT | P42858 | 5/20 | 0.50 |
| ▸ | GAA | P10253 | 5/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.50 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 6/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | PTBP1 | P26599 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2619262 | 1.00 | RAB9A (0.50) | RAB9ATDP1MAPTHTTGAA | |
| SCHEMBL745118 | 1.00 | RAB9A (0.50) | RAB9ATDP1MAPTHTTGAA | |
| SCHEMBL11332706 | 0.83 | MAPT (0.52) | RAB9ATDP1MAPTHTTGAA | |
| SCHEMBL11327606 | 0.83 | MAPT (0.52) | RAB9ATDP1MAPTHTTGAA | |
| SCHEMBL745116 | 0.77 | RAB9A (0.49) | RAB9ATDP1MAPTHTTGAA | |
| SCHEMBL745117 | 0.77 | RAB9A (0.49) | RAB9ATDP1MAPTHTTGAA | |
| SCHEMBL21838458 | 0.77 | RAB9A (0.49) | RAB9ATDP1MAPTHTTGAA | |
| SCHEMBL21838460 | 0.77 | RAB9A (0.49) | RAB9ATDP1MAPTHTTGAA | |
| SCHEMBL30220799 | 0.77 | RAB9A (0.49) | RAB9ATDP1MAPTHTTGAA | |
| SCHEMBL15992321 | 0.74 | KMT2A (0.37) | RAB9ATDP1MAPTHTTGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 516 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11650203-B2 | One-pot biosensor and immunoassay method using the same | GIST (Gwangju Institute of Science and Technology) (KR) | 2023-05-16 | — | — | US | claimed |
| US-12636325-B2 | Probiotic compositions for treating and preventing colorectal cancer | THE CHINESE UNIVERSITY OF HONG KONG (CN) | 2026-05-26 | — | — | US | disclosed |
| CN-116768801-B | Condensed quinone oxime imidazoles and their onium derivatives, their preparation and use | 上海交通大学 | 2026-05-19 | — | — | CN | disclosed |
| US-12630589-B2 | Compounds for use in viral infections | PHARMA MAR, S.A. (ES) | 2026-05-19 | — | — | US | disclosed |
| CN-122038528-A | LDHA enzyme activity detection method based on MTS color development system | 深圳大学 | 2026-05-15 | — | — | CN | disclosed |
| CN-119954744-B | Aspirin-sulfonamide hybrid, and preparation method and application thereof | 宁夏大学 | 2026-05-15 | — | — | CN | disclosed |
| WO-2026100855-A1 | METHOD FOR PREPARING EXOSOMES ISOLATED FROM WHARTON'S JELLY-DERIVED MESENCHYMAL STEM CELLS, AND COSMETIC MATERIAL COMPOSITION COMPRISING EXOSOMES PREPARED USING SAME | 주식회사 파나셀바이오텍 | 2026-05-15 | — | — | WO | disclosed |
| US-12616681-B2 | Compositions and methods for treating renal injury | CASE WESTERN RESERVE UNIVERSITY (US) | 2026-05-05 | — | — | US | disclosed |
| US-12605485-B2 | Nanoparticles to promote wound healing and antimicrobial infection control | KISMET TECHNOLOGIES INC. (US) | 2026-04-21 | — | — | US | disclosed |
| US-12599698-B2 | Therapeutic article of manufacture with nanoparticles to promote wound healing and/or antimicrobial infection control | KISMET TECHNOLOGIES INC. (US) | 2026-04-14 | — | — | US | disclosed |
| US-10544140-B2 | Pharmaceutical composition containing, as active ingredient, 7-azaindolin-2-one derivative or pharmaceutically acceptable salt thereof | LG CHEM, LTD. (KR) | 2020-01-28 | — | — | US | disclosed |
| US-20180370964-A1 | PHARMACEUTICAL COMPOSITION CONTAINING, AS ACTIVE INGREDIENT, 7-AZAINDOLIN-2-ONE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | LG CHEM, LTD. (KR) | 2018-12-27 | — | — | US | disclosed |
| EP-3363799-A1 | PHARMACEUTICAL COMPOSITION CONTAINING, AS ACTIVE INGREDIENT, 7-AZAINDOLIN-2-ONE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | LG Chem, Ltd. (KR) | 2018-08-22 | — | — | EP | disclosed |
| US-8188144-B2 | In vitro preservation of living animal cells and compounds suitable for use in the preservation of living animal cells | ANTOXIS LIMITED (GB) | 2012-05-29 | — | — | US | disclosed |
| US-8188144-B2 | In vitro preservation of living animal cells and compounds suitable for use in the preservation of living animal cells | ANTOXIS LIMITED (GB) | 2012-05-29 | — | — | US | disclosed |
| US-20100267132-A1 | IN VITRO PRESERVATION OF LIVING ANIMAL CELLS AND COMPOUNDS SUITABLE FOR USE IN THE PRESERVATION OF LIVING ANIMAL CELLS | ANTOXIS LIMITED (GB) | 2010-10-21 | — | — | US | disclosed |
| US-20100267132-A1 | IN VITRO PRESERVATION OF LIVING ANIMAL CELLS AND COMPOUNDS SUITABLE FOR USE IN THE PRESERVATION OF LIVING ANIMAL CELLS | ANTOXIS LIMITED (GB) | 2010-10-21 | — | — | US | disclosed |
| WO-2009047568-A2 | IN VITRO PRESERVATION OF LIVING ANIMAL CELLS AND COMPOUNDS SUITABLE FOR USE IN THE PRESERVATION OF LIVING ANIMAL CELLS | ANTOXIS LIMITED (GB) | 2009-04-16 | — | — | WO | disclosed |
| US-4292399-A | Cobalt (III) complex imaging compositions having improved photographic properties | EASTMAN KODAK COMPANY (US) | 1981-09-29 | — | — | US | disclosed |
| US-4171221-A | NONSILVER PHOTOGTAPHY | EASTMAN KODAK COMPANY (US) | 1979-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180370964-A1 | PHARMACEUTICAL COMPOSITION CONTAINING, AS ACTIVE INGREDIENT, 7-AZAINDOLIN-2-ONE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | HDAC6, AZI2, HDAC7 | RAB9A 456/4885TDP1 4034/4885MAPT 2452/4885 |
| US-10544140-B2 | Pharmaceutical composition containing, as active ingredient, 7-azaindolin-2-one derivative or pharmaceutically acceptable salt thereof | AZI2, HDAC7, CYP3A7 | RAB9A 779/4885TDP1 1403/4885MAPT 3389/4885 |
| US-12616681-B2 | Compositions and methods for treating renal injury | PTGIS, PTGS1, PTGS2 | RAB9A 3504/4885TDP1 4727/4885MAPT 4830/4885 |
| US-20100267132-A1 | IN VITRO PRESERVATION OF LIVING ANIMAL CELLS AND COMPOUNDS SUITABLE FOR USE IN THE PRESERVATION OF LIVING ANIMAL CELLS | PIGS, AQP1, F12 | RAB9A 3789/4885TDP1 1755/4885MAPT 3710/4885 |
| US-12599698-B2 | Therapeutic article of manufacture with nanoparticles to promote wound healing and/or antimicrobial infection control | ARG1, CD68, MIF | RAB9A 3160/4885TDP1 3313/4885MAPT 1219/4885 |
| US-12630589-B2 | Compounds for use in viral infections | MIF, MAVS, NISCH | RAB9A 3267/4885TDP1 2448/4885MAPT 1389/4885 |
| US-12605485-B2 | Nanoparticles to promote wound healing and antimicrobial infection control | CUTA, ITGB3, ITGA2 | RAB9A 2680/4885TDP1 3557/4885MAPT 2972/4885 |
| US-12636325-B2 | Probiotic compositions for treating and preventing colorectal cancer | LCT, SI, LDHA | RAB9A 2453/4885TDP1 4305/4885MAPT 935/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.